BRIEF-BioCryst reports additional positive results from second interim analysis of APEX-1 trial
May 25, 2017 at 08:16 AM EDT
* BioCryst reports additional positive results from the second interim analysis of its APEX-1 trial
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.